Literature DB >> 8511593

Chondroscopy: a new method for scoring chondropathy.

X Ayral1, M Dougados, V Listrat, J P Bonvarlet, J Simonnet, S Poiraudeau, B Amor.   

Abstract

The purpose of this study was to evaluate the performance (simplicity, reproducibility, relevance) of chondroscopy as a method for evaluating cartilage damage. Chondroscopy consisted in endoscopic evaluation of the knee using a 2.7-mm Storz arthroscope under local anesthesia and recorded on videotape. Scoring of chondropathy was based on physician's overall assessment using a 100-mm-length visual analogue scale (VAS) and size and grade of cartilage lesions. Reproducibility was evaluated by variability (coefficient of variation [CV]) in the reading of chondroscopic evaluations of five patients five times by one physician and one time each by four different physicians. The correlations between scoring of chondropathy (VAS) and radiological articular joint space narrowing, demographic data (sex, age, weight), and disease characteristics (localization, etiology, activity) were studied in 84 outpatients fulfilling the American College of Rheumatology criteria for the diagnosis of osteoarthritis of the knee. The grade and size of the lesions were both correlated with the physician's overall assessment (r = 0.713 and r = 0.816, respectively). These two variables accounted for 72% of the variance of the VAS (multiple regression analysis). Intraobserver reproducibility was better than interobserver reproducibility (CV, 9% and 37%, respectively). There was a strong correlation between the scoring of chondropathy (VAS) and radiological joint space narrowing (r = .646, P < .0001). Moreover, in 17 of 33 patients without radiological joint space narrowing, VAS was > 20 mm. At variance, the body mass index was the single clinical variable found to correlate with the scoring of chondropathy (r = .282, P < .001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8511593     DOI: 10.1016/s0049-0172(05)80008-3

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  9 in total

1.  Viability of chondroscopy as a means of cartilage assessment.

Authors:  X Ayral; M Dougados
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

Review 2.  Clinical trials in osteoarthritis.

Authors:  L M March; P M Brooks
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

3.  Mapping tibiofemoral gonarthrosis: an MRI analysis of non-traumatic knee cartilage defects.

Authors:  D S Evangelopoulos; M Huesler; S S Ahmad; E Aghayev; M Neukamp; C Röder; A Exadaktylos; H Bonel; S Kohl
Journal:  Br J Radiol       Date:  2015-06-17       Impact factor: 3.039

4.  Instruments to assess osteoarthritis--current status and future needs.

Authors:  N Bellamy
Journal:  Ann Rheum Dis       Date:  1995-09       Impact factor: 19.103

Review 5.  Diagnosis of osteoarthritis. Guidelines and current pitfalls.

Authors:  G Bálint; B Szebenyi
Journal:  Drugs       Date:  1996       Impact factor: 9.546

6.  Association between quantitative MRI and ICRS arthroscopic grading of articular cartilage.

Authors:  Victor Casula; Jukka Hirvasniemi; Petri Lehenkari; Risto Ojala; Marianne Haapea; Simo Saarakkala; Eveliina Lammentausta; Miika T Nieminen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-09-11       Impact factor: 4.342

7.  Arthroscopic Measurement of Cartilage Lesions of the Knee Condyle: Principles and Experimental Validation of a New Method.

Authors:  Henri Robert; Jean Christophe Lambotte; Rémi Flicoteaux
Journal:  Cartilage       Date:  2011-07       Impact factor: 4.634

8.  Diagnostic needle arthroscopy and the economics of improved diagnostic accuracy: a cost analysis.

Authors:  Jeffrey D Voigt; Michael Mosier; Bryan Huber
Journal:  Appl Health Econ Health Policy       Date:  2014-10       Impact factor: 2.561

9.  In-office diagnostic arthroscopy for knee and shoulder intra-articular injuries its potential impact on cost savings in the United States.

Authors:  Jeffrey D Voigt; Michael Mosier; Bryan Huber
Journal:  BMC Health Serv Res       Date:  2014-05-05       Impact factor: 2.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.